Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: The HPV in men study

Journal of Infectious Diseases

Volumn 204, Issue 12, 2011, Pages 1886-1892

  Anic, Gabriella M ^a,b   Lee, Ji Hyun ^a   Stockwell, Heather ^b   Rollison, Dana E ^a   Wu, Yougui ^b   Papenfuss, Mary R ^a   Villa, Luisa L ^c   Lazcano Ponce, Eduardo ^d   Gage, Christine ^a   Silva, Roberto José C ^e   Baggio, Maria L ^c   Quiterio, Manuel ^d,f   Salmerón, Jorge ^d,f   Abrahamsen, Martha ^a   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e HIV AIDS Reference and Treatment Center in São Paulo   (Brazil)

^f INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; EARLY DIAGNOSIS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; WART VIRUS;

ADOLESCENT; ADULT; AGED; CONDYLOMATA ACUMINATA; DNA, VIRAL; GENOTYPE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PENILE DISEASES; PREVALENCE; TIME FACTORS; YOUNG ADULT;

EID: 81055147100     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir652     Document Type: Article

References (24)

1. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2-7. (Pubitemid 29177834)
2. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/35-41.
3. Dinh TH, Sternberg M, Dunne EF, Markowitz LE. Genital warts among 18-to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis 2008; 35:357-60. (Pubitemid 351440776)
4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8. (Pubitemid 127695953)
5. Jeynes C, Chung MC, Challenor R. 'Shame on you'dthe psychosocial impact of genital warts. Int J STD AIDS 2009; 20:557-60.
6. Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002; 35:S210-24. (Pubitemid 35178333)
7. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971; 47:1-13.
8. Lacey CJ. Therapy for genital human papillomavirus-related disease. J Clin Virol 2005; 32(Suppl 1):S82-90. (Pubitemid 40332593)
9. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirusrelated disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005; 23:1107-22. (Pubitemid 41633402)
10. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl JMed 2011; 364:401-11.
11. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36:1397-403. (Pubitemid 36702873)
12. Koshiol JE, Laurent SA, Pimenta JM. Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis 2004; 31:748-52. (Pubitemid 39557423)
13. Hoy T, Singhal PK, Willey VJ, Insinga RP. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin 2009; 25:2343-51.
14. Arima Y, Winer RL, Feng Q, et al. Development of genital warts after incident detection of human papillomavirus infection in young men. J Infect Dis 2010; 202:1181-4.
15. Giuliano AR, Lazcano E, Villa LL, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009; 124:1251-7.
16. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17:2036-43.
17. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932-40.
18. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131:373-5. (Pubitemid 20118904)
19. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199:805-14.
20. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191:731-8. (Pubitemid 40271061)
21. Chan PK, Luk AC, Luk TN, et al. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol 2009; 44:111-4.
22. Aubin F, Pretet JL, Jacquard AC, et al. Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis 2008; 47:610-5.
23. Greer CE,Wheeler CM, LadnerMB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995; 33:2058-63.
24. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37:3316-22. (Pubitemid 29455226)